BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3465311)

  • 1. Hypothyroidism and Graves' disease after mantle irradiation: a follow up study.
    Mortimer RH; Hill GE; Galligan JP; Bransden AI; Tyack SA; Roeser HP
    Aust N Z J Med; 1986 Jun; 16(3):347-51. PubMed ID: 3465311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid diseases after treatment of Hodgkin's disease.
    Hancock SL; Cox RS; McDougall IR
    N Engl J Med; 1991 Aug; 325(9):599-605. PubMed ID: 1861693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum thyroglobulin after mantle irradiation for Hodgkin's disease.
    Holt G; Galligan J; Winship J; Roeser P; Mortimer R
    Clin Endocrinol (Oxf); 1983 Jun; 18(6):605-11. PubMed ID: 6411392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of Graves' disease following radiation therapy in Hodgkin's disease.
    Loeffler JS; Tarbell NJ; Garber JR; Mauch P
    Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):175-8. PubMed ID: 3335451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of transient hypothyroidism after iodine-131 treatment in hyperthyroid patients with Graves' disease: prevalence, mechanism and prognosis.
    Aizawa Y; Yoshida K; Kaise N; Fukazawa H; Kiso Y; Sayama N; Hori H; Abe K
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):1-5. PubMed ID: 9059550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graves' disease with ophthalmopathy following radiotherapy for Hodgkin's disease.
    Jacobson DR; Fleming BJ
    Am J Med Sci; 1984 Dec; 288(5):217-20. PubMed ID: 6334992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
    Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
    J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid dysfunction following external irradiation to the neck for Hodgkin's disease in childhood.
    Shalet SM; Rosenstock JD; Beardwell CG; Pearson D; Jones PH
    Clin Radiol; 1977 Sep; 28(5):511-5. PubMed ID: 589902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continued suppression of serum TSH level may be attributed to TSH receptor antibody activity as well as the severity of thyrotoxicosis and the time to recovery of thyroid hormone in treated euthyroid Graves' patients.
    Chung YJ; Lee BW; Kim JY; Jung JH; Min YK; Lee MS; Lee MK; Kim KW; Chung JH
    Thyroid; 2006 Dec; 16(12):1251-7. PubMed ID: 17199435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term hyperthyroidism followed by transient pituitary hypothyroidism in a very low birth weight infant born to a mother with uncontrolled Graves' disease.
    Higuchi R; Kumagai T; Kobayashi M; Minami T; Koyama H; Ishii Y
    Pediatrics; 2001 Apr; 107(4):E57. PubMed ID: 11335778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DR3 and DRw6: prognostic factors for the incidence of hypothyroidism in Graves' disease after radioiodine treatment.
    Althaus B; Straub JJ; Neri TM; Hauenstein M; Müller-Brand J; Berger W; Farid NR
    Acta Endocrinol (Copenh); 1986 Nov; 113(3):323-8. PubMed ID: 3788412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid response, especially to thyrotropin-binding inhibitory immunoglobulins, in euthyroid relatives of patients with Graves' disease: a clinical follow-up.
    Tamai H; Kasagi K; Morita T; Hidaka A; Kuma K; Konishi J; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1990 Jul; 71(1):210-5. PubMed ID: 1973421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A long-term follow-up study of patients with non-toxic diffuse goitre in Japan.
    Hara T; Tamai H; Mukuta T; Fukata S; Kuma K; Nakagawa T
    Clin Endocrinol (Oxf); 1993 Nov; 39(5):541-6. PubMed ID: 8252742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves' disease.
    Uy HL; Reasner CA; Samuels MH
    Am J Med; 1995 Aug; 99(2):173-9. PubMed ID: 7625422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in thyroid function in euthyroid subjects with a family history of Graves' disease: a follow-up study of 69 patients.
    Tamai H; Ohsako N; Takeno K; Fukino O; Takahashi H; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1980 Nov; 51(5):1123-7. PubMed ID: 6774999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on thyrotrophin receptor antibodies in patients with euthyroid Graves' disease.
    Kasagi K; Hatabu H; Tokuda Y; Iida Y; Endo K; Konishi J
    Clin Endocrinol (Oxf); 1988 Oct; 29(4):357-66. PubMed ID: 2908031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ophthalmopathy after neck irradiation therapy for Hodgkin's disease.
    Jackson R; Rosenberg C; Kleinmann R; Vagenakis AG; Braverman LE
    Cancer Treat Rep; 1979 Aug; 63(8):1393-5. PubMed ID: 582577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.